UBS Group
RVMDW icon

UBS Group’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

UBS Group’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Buy
2,461
+1,575
+178% +$8.52K ﹤0.01% 8073
2026
Q1 		$1.59K Buy
+886
New +$1.72K ﹤0.01% 9492
2025
Q1 		– Sell
-2,692
Closed -$485 – 10650
2024
Q4 		$485 Buy
2,692
+2,664
+9,514% +$788 ﹤0.01% 9453
2024
Q3 		$4 Sell
28
-447
-94% -$54 ﹤0.01% 9397
2024
Q2 		$48 Buy
475
+384
+422% +$80 ﹤0.01% 9236
2024
Q1 		$17 Sell
91
-880
-91% -$178 ﹤0.01% 9053
2023
Q4 		$320 Buy
+971
New +$434 ﹤0.01% 8728

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

UBS Group's RVMDW Position: Q2 2026 in Review

UBS Group increased its Revolution Medicines Inc Warrant (RVMDW) stake by 178% in Q2 2026, buying an estimated $8.52K and bringing the position to 2,461 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #8073.

UBS Group first reported a position in RVMDW in Q4 2023 and has held it in 7 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • UBS Group held 2,461 shares of Revolution Medicines Inc Warrant worth $23.1K as of Q2 2026.
  • UBS Group bought 1,575 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $8.52K.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8073 holding.
  • UBS Group first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 7 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.